Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial ATP-sensitive potassium channel (mitoKATP) complex is a critical regulator of mitochondrial physiology and cellular survival, primarily located in the inner mitochondrial membrane [Foster et al., 2014, PubMed: 24906953]. While its molecular identity was long debated, research has identified the ATP-sensitive inward rectifier potassium channel 1 (KCNJ1/ROMK) as a key pore-forming subunit of this complex in cardiac tissue [Foster et al., 2014; UniProt: P48544]. The channel opens in response to metabolic stress, such as a drop in the ATP/ADP ratio, allowing potassium ions to enter the mitochondrial matrix [Paggio et al., 2019, PubMed: 30639142]. This influx leads to mild mitochondrial depolarization and matrix swelling, which modulates reactive oxygen species (ROS) production and prevents the opening of the mitochondrial permeability transition pore (mPTP) [O'Rourke, 2004, PubMed: 15151911]. Pharmacological activation of the mitoKATP complex, using drugs like diazoxide, is a well-known mechanism for inducing ischemic preconditioning, which protects the heart and brain from ischemia-reperfusion injury [Garlid & Halestrap, 2012, PubMed: 22266134]. However, therapeutic targeting is challenged by the need for mitochondrial specificity to avoid off-target effects on plasma membrane KATP channels, which can cause hypotension or impaired insulin secretion [PubChem CID: 3019].
Activation of the channel allows potassium ions to enter the mitochondrial matrix, leading to mild depolarization of the inner mitochondrial membrane and regulation of mitochondrial volume and ROS production, which confers cytoprotection during stress [Foster et al., 2014; O'Rourke, 2004].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-sensitive inward rectifier potassium channel 1 (mitochondrial complex) (mitoKATP).